April 2013 - Volume 17 - Issue - Contributor Index

Alphabetical Search
A
B
D
I
J
N
O
Q
R
T
U
V
X
Y
Z

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease . 17:S28-S35, April 2013.

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease . 17:S36-S42, April 2013.

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease . 17:S43-S49, April 2013.

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease . 17:S50-S55, April 2013.

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease . 17:S56-S63, April 2013.

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease . 17:S64-S68, April 2013.

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Katki, Hormuzd A.; Gage, Julia C.; Schiffman, Mark; More

Journal of Lower Genital Tract Disease . 17:S69-S77, April 2013.

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease . 17:S78-S84, April 2013.